About LeMaitre Vascular
LeMaitre Vascular is a company based in Burlington (United States) founded in 1983. LeMaitre Vascular has raised $5.83 million across 7 funding rounds. The company has 664 employees as of December 31, 2024. LeMaitre Vascular has completed 5 acquisitions, including Artegraft, Duke Vascular and Inavein. LeMaitre Vascular offers products and services including AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®. LeMaitre Vascular operates in a competitive market with competitors including Avinger, Pathway Medical Technologies, Intact Vascular, Okami Medical and Cagent Vascular, among others.
- Headquarter Burlington, United States
- Employees 664 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lemaitre Vascular, Inc.
-
Annual Revenue
$219.86 M (USD)13.63as on Dec 31, 2024
-
Net Profit
$44.04 M (USD)46.28as on Dec 31, 2024
-
EBITDA
$62 M (USD)33.05as on Dec 31, 2024
-
Total Equity Funding
$5.83 M (USD)
in 7 rounds
-
Latest Funding Round
$25 K (USD), Series A
Sep 01, 2005
-
Investors
Not available
-
Employee Count
664
as on Dec 31, 2024
-
Investments & Acquisitions
Artegraft
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of LeMaitre Vascular
LeMaitre Vascular is a publicly listed company on the NASDAQ with ticker symbol LMAT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of LeMaitre Vascular
LeMaitre Vascular offers a comprehensive portfolio of products and services, including AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®.
Polyester grafts for aortic repair and vascular procedures
Allografts for cardiac and vascular reconstruction
Catheters used for vascular occlusion in surgeries
Devices for secure vascular closure during procedures
People of LeMaitre Vascular
Unlock access to complete
Sales and Marketing
30 people
Software Development Team
22 people
Leadership Team
9 people
Senior Team
7 people
Operations Team
7 people
Human Resources and Administration
6 people
Product Management Team
4 people
Finance and Accounting
3 people
Unlock access to complete
Funding Insights of LeMaitre Vascular
LeMaitre Vascular has successfully raised a total of $5.83M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $25 thousand completed in September 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by LeMaitre Vascular
LeMaitre Vascular has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Artegraft, Duke Vascular and Inavein.
Investment portfolio details for LeMaitre Vascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Regenerative medicines from human tissues are developed for multiple diseases.
|
Locked | Locked | 2013 | Locked | |
|
Rupture management kits and tracker delivery systems are manufactured.
|
Locked | Locked | 2008 | Locked | |
|
Varicose and spider vein treatment devices are developed and marketed.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for LeMaitre Vascular
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - LeMaitre Vascular
Detailed financials for LeMaitre Vascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lemaitre Vascular Comparisons
Peer comparison for LeMaitre Vascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LeMaitre Vascular
LeMaitre Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, Pathway Medical Technologies, Intact Vascular, Okami Medical and Cagent Vascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of image-guided catheter-based products for peripheral artery disease
|
|
| Locked | Locked | Locked |
Smart devices are provided to clear peripheral arterial blockages.
|
|
| Locked | Locked | Locked |
Implants for repairing arteries after angioplasty are developed.
|
|
| Locked | Locked | Locked |
Innovative medical devices for peripheral vessel treatment are developed.
|
|
| Locked | Locked | Locked |
Devices for removing vascular blockages are developed.
|
Detailed competitors of LeMaitre Vascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lemaitre Vascular
Complete news archive for LeMaitre Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LeMaitre Vascular
LeMaitre Vascular was founded in 1983 and raised its 1st funding round 19 years after it was founded.
LeMaitre Vascular is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
LeMaitre Vascular is a funded company, having raised a total of $5.83M across 7 funding rounds to date.
As of Dec 31, 2024, the latest employee count at LeMaitre Vascular is 664.
Annual revenue of LeMaitre Vascular is $219.86M as on Dec 31, 2024.
LeMaitre Vascular was founded in 1983 and focuses on the development, manufacturing, and marketing of medical devices and implants for peripheral vascular disease. Products such as embolectomy catheters, occlusion catheters, perfusion catheters, and carotid shunts are produced. Operations extend worldwide from the headquarters in Burlington, United States. The company, formerly known as Vascutech, underwent a name change in April 2001.
LeMaitre Vascular's top competitors include Avinger, Okami Medical and Cagent Vascular.
LeMaitre Vascular offers AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®.
Yes, LeMaitre Vascular is publicly traded on NASDAQ under the ticker symbol LMAT.
LeMaitre Vascular has made 5 acquisitions, including Artegraft, Duke Vascular, and Inavein.
The ticker symbol of LeMaitre Vascular is LMAT on NASDAQ.